HORMONAL EFFECTS, TOLERABILITY, AND PRELIMINARY KINETICS IN MEN OF MK-906, A 5-ALPHA-REDUCTASE INHIBITOR

被引:28
|
作者
DESCHEPPER, PJ
IMPERATOMCGINLEY, J
VANHECKEN, A
DELEPELEIRE, I
BUNTINX, A
CARLIN, J
GRESSI, MH
STONER, E
机构
[1] Department of Pharmacology and Clinical Pharmacology, University of Leuven, School of Medicine, Leuven
[2] Cornell University Medical College, New York, NY
[3] Merck Sharp and Dohme Research Laboratories, Rahway, NJ
关键词
STEROIDS; 5-ALPHA-REDUCTASE INHIBITOR; PHARMACODYNAMICS; DIHYDROTESTOSTERONE; TESTOSTERONE; HUMAN; PHARMACOKINETICS; FINASTERIDE;
D O I
10.1016/0039-128X(91)90003-E
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hormonal effects following the acute (single dose) administration of a 4-azasteroid inhibitor of 5-alpha-reductase (MK-906) were evaluated in 10 healthy male volunteers. Marked suppression of serum dihydrotestosterone (DHT) was observed after the administration of single doses as low as 12.5 mg. The mean percent decrease in DHT at 24 hours in the group treated with a single 25-mg dose was 56% +/- 10% compared with the baseline. The suppression of plasma DHT levels continued for up to 72 hours. This study demonstrates that administration of single oral doses (12.5 to 400 mg) of MK-906 results in a significant decrease in the conversion of testosterone to DHT.
引用
收藏
页码:469 / 471
页数:3
相关论文
共 50 条
  • [31] 5-ALPHA-REDUCTASE INHIBITORS IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Dai, Charles
    Ganesan, Vishnu
    Zabell, Joseph
    Nyame, Yaw
    Hettel, Daniel
    Almassi, Nima
    Greene, Daniel
    Haywood, Samuel
    Reichard, Chad
    Zampini, Anna
    Crane, Alice
    Arora, Hans
    El-Shafei, Ahmed
    Stein, Robert
    Fareed, Khaled
    Gong, Michael
    Jones, J. Stephen
    Stephenson, Andrew
    Klein, Eric
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E229 - E229
  • [32] STUDIES ON THE MECHANISM OF THE ANTIANDROGENIC EFFECT OF A PUTATIVE 5-ALPHA-REDUCTASE INHIBITOR
    VAZQUEZ, MH
    TEZON, JG
    BLAQUIER, JA
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 28 (02): : 227 - 231
  • [33] Synthesis of 5-alpha-reductase inhibitor L-751,788
    Li, WJ
    Miller, RA
    Humphrey, GR
    Chung, JY
    Zhao, DL
    Farr, R
    McNamara, JM
    Grabowski, EJJ
    Reider, PJ
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 105 - ORGN
  • [34] EFFECTS OF AN IRREVERSIBLE INHIBITOR OF 5-ALPHA-REDUCTASE ON ORNITHINE DECARBOXYLASE ACTIVITY IN THE RAT VENTRAL PROSTATE
    MARTS, SA
    PADILLA, GM
    PETROW, V
    [J]. JOURNAL OF CELL BIOLOGY, 1986, 103 (05): : A348 - A348
  • [35] INVITRO EFFECTS OF AN AROMATASE INHIBITOR ON 5-ALPHA-REDUCTASE ACTIVITY IN HUMAN HYPERTROPHIC PROSTATIC TISSUE
    ZOPPI, S
    COCCONI, M
    NATALI, A
    COSTANTINI, A
    SERIO, M
    MARTINI, L
    MOTTA, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (01): : 269 - 271
  • [36] DETERMINATION OF CUTANEOUS ACTIVITY OF 5-ALPHA-REDUCTASE - A PRELIMINARY-STUDY
    DERIOLS, C
    MOATTI, JP
    MILLET, P
    BONAFE, JL
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1985, 112 (12): : 1008 - 1008
  • [37] A HIGH-AFFINITY INHIBITOR OF PITUITARY PROGESTERONE 5-ALPHA-REDUCTASE
    BERTICS, PJ
    EDMAN, CF
    KARAVOLAS, HJ
    [J]. ENDOCRINOLOGY, 1984, 114 (01) : 63 - 69
  • [38] IMPROVED SYNTHESES OF EPRISTERIDE, A POTENT HUMAN 5-ALPHA-REDUCTASE INHIBITOR
    BAINE, NH
    OWINGS, FF
    KLINE, DN
    RESNICK, T
    PING, LJ
    FOX, M
    MEWSHAW, RE
    TICKNER, AM
    KOWALSKI, CJ
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (20): : 5987 - 5989
  • [39] 5-Alpha-reductase inhibitor and benign prostatic hypertrophy Impact on size ;
    Ismael, Ayad Abdulkhaleq
    Raoof, Abdulla Adill
    [J]. JOURNAL OF WILDLIFE AND BIODIVERSITY, 2023, 7 : 437 - 442
  • [40] STUDIES ON THE KINETICS OF THE INTERACTION OF 7-ALPHA-HYDROXYTESTOSTERONE WITH THE STEROID 5-ALPHA-REDUCTASE
    MITTLER, JC
    [J]. STEROIDS, 1985, 45 (02) : 135 - 142